Our latest updates
02 Mar, 2026
According to the report, the market is valued at USD 946.0 million in 2026, which is expected to grow to USD 1,135.3 million by 2034. The projected CAGR for this period is 4.2%.
02 Mar, 2026
According to the report, the market is valued at USD 4.5 billion in 2026, which is expected to grow to USD 6.7 billion by 2034. The projected CAGR for this period is 5.1%.
27 Feb, 2026
According to the report, the market is valued at USD 11.1 billion in 2026, which is expected to grow to USD 16.8 billion by 2034. The projected CAGR for this period is 5.3%.
27 Feb, 2026
The farm animal healthcare market size was valued at USD 23.38 billion in 2025. By product, the pharmaceuticals segment dominated the market with a revenue share of 48.73%.
27 Feb, 2026
According to the report, the market is valued at USD 223.4 billion in 2026, which is expected to grow to USD 435.2 billion by 2034. The projected CAGR for this period is 8.6%.
27 Feb, 2026
The hospital supplies market size was valued at USD 56 billion in 2025. By product type, disposable hospital supplies segment accounted for the largest share of 47%.
27 Feb, 2026
According to the report, the market is valued at USD 45.9 billion in 2026, which is expected to grow to USD 68.2 billion by 2034. The projected CAGR for this period is 5.6%.
27 Feb, 2026
The calciphylaxis market size was valued at USD 1.4 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 2.8 billion by 2034 at a CAGR of 8.0% during the forecast period (2026-2034), as per Straits Research Analysis.
26 Feb, 2026
The hospital acquired infection or HAI control market size was valued at USD 21.36 billion in 2025. North America dominated the market with the largest share of 50.77%.
26 Feb, 2026
The contrast media injectors market size was valued at USD 2.45 billion in 2025. By product, the injector systems segment is expected to register a CAGR of 10.45% during the forecast period.
26 Feb, 2026
The molecular biology enzymes, kits, and reagents market size was valued at USD 15.42 billion in 2025. By product, the kits & reagents segment dominated the market with the largest share.
26 Feb, 2026
The pharmaceutical R&D outsourcing market size was valued at USD 85 billion in 2025. North America dominated the market with the largest share of 40.5%.
sales@straitsresearch.com
